RxDoctor Payments Data

Marianne Peacock, NP

Family · Traverse City, MINPI 1386631455

Payments from drug & device makers

$3,864in general payments, 2019–2025

Across 245 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • AbbVie$604
  • Novartis$397
  • Pfizer$393
  • Johnson & Johnson$326
  • UCB, Inc.$98
  • plus $388 from 8 others

What the payments were for

  • Food & beverage$3,73997%
  • Education$1253%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,864 in reported general payments places this provider in the 90th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$653,468
Medicare patients
283
Services billed
33,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab116$911,777
Enbrel SureclickEtanercept110$835,406
EnbrelEtanercept72$605,251
Humira PenAdalimumab30$244,751
Humira(Cf)Adalimumab26$174,755
Orencia ClickjectAbatacept28$174,095
Xeljanz XrTofacitinib Citrate16$147,920
OrenciaAbatacept20$144,793
Cimzia (2 Pack)Certolizumab Pegol15$86,039
Cosentyx Sensoready PenSecukinumab12$84,625
HumiraAdalimumab12$81,738
Hydroxychloroquine Sulfate713$47,423
MethotrexateMethotrexate Sodium525$25,425
Sulfasalazine DrSulfasalazine66$6,064
Leflunomide31$2,586

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEnbrel$1,658$605,25172 claims
AbbVieHumira(Cf), Humira$604$256,49338 claims
E.r. Squibb & Sons, L.L.C.Orencia$86$144,79320 claims
UCB, Inc.Cimzia (2 Pack)$98$86,03915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,657 family providers in Michigan.

Other family in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →